Bausch Health Companies | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Amgen USD 6.21B 330M 2025-03
ANI Pharmaceuticals USD 418.62M 14.94M 2025-03
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bausch Health Companies USD -1183000000 861M 2025-03
Biogen USD 16.98B 262.7M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 683.28M 3.7M 2025-03
Danaher USD 50.85B 1.31B 2025-03
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Novo Nordisk 138.54B 18.02B 2025-03
Pacira USD 798.54M 20.19M 2025-03
Perrigo USD 4.36B 44.6M 2025-03
Prestige Brands USD 1.83B 46.46M 2025-03
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Zoetis USD 4.66B 115M 2025-03



Bausch Health Companies Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.